10-K Filing
Filing Information
| Form Type | 10-K |
| Accession Number | 0001350102-17-000041 |
| Period End Date | 20161231 |
| Filing Date | 20170417 |
| Fiscal Year | 2016 |
| Fiscal Period | FY |
| XBRL Instance | asti-20161231.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
80 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$130.95K | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$326.22K | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$3.32M | USD | Point-in-time |
| Trade receivables, net |
AccountsReceivableNetCurrent
|
$1.99M | USD | Point-in-time |
| Trade receivables, net |
AccountsReceivableNetCurrent
|
$549.20K | USD | Point-in-time |
| Inventories |
InventoryNet
|
$2.57M | USD | Point-in-time |
| Inventories |
InventoryNet
|
$4.27M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$1.39M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$983.80K | USD | Point-in-time |
| Patents, amortization |
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
$279.14K | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$7.99M | USD | Point-in-time |
| Patents, amortization |
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
$169.63K | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$4.23M | USD | Point-in-time |
| Property, Plant and Equipment: |
PropertyPlantAndEquipmentGross
|
$36.64M | USD | Point-in-time |
| Property, Plant and Equipment: |
PropertyPlantAndEquipmentGross
|
$37.58M | USD | Point-in-time |
| Less accumulated depreciation and amortization |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$30.98M | USD | Point-in-time |
| Less accumulated depreciation and amortization |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$28.48M | USD | Point-in-time |
| Net property, plant and equipment |
PropertyPlantAndEquipmentNet
|
$9.09M | USD | Point-in-time |
| Net property, plant and equipment |
PropertyPlantAndEquipmentNet
|
$5.66M | USD | Point-in-time |
| Preferred stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
25.00M | shares | Point-in-time |
| Patents, net of accumulated amortization of $279,143 and $169,626, respectively |
FiniteLivedIntangibleAssetsNet
|
$1.57M | USD | Point-in-time |
| Patents, net of accumulated amortization of $279,143 and $169,626, respectively |
FiniteLivedIntangibleAssetsNet
|
$1.65M | USD | Point-in-time |
| Other non-current assets |
OtherAssetsNoncurrent
|
$77.56K | USD | Point-in-time |
| Other non-current assets |
OtherAssetsNoncurrent
|
$105.31K | USD | Point-in-time |
| Total other assets |
OtherAssets
|
$1.67M | USD | Point-in-time |
| Total other assets |
OtherAssets
|
$1.73M | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Total Assets |
Assets
|
$18.75M | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Total Assets |
Assets
|
$11.61M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
450.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
2.00B | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
7.76M | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
554.22M | shares | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
7.76M | shares | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
554.22M | shares | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$4.90M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$3.63M | USD | Point-in-time |
| Related party payables |
AccountsPayableRelatedPartiesCurrent
|
$214.90K | USD | Point-in-time |
| Related party payables |
AccountsPayableRelatedPartiesCurrent
|
- | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$1.71M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$1.47M | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtCurrent
|
$243.11K | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtCurrent
|
$348.72K | USD | Point-in-time |
| Current portion of convertible note payable, net of discount of $0 and $22,484, respectively |
ConvertibleNotesPayableCurrent
|
- | USD | Point-in-time |
| Current portion of convertible note payable, net of discount of $0 and $22,484, respectively |
ConvertibleNotesPayableCurrent
|
$30.04K | USD | Point-in-time |
| Promissory Notes |
PromissoryNoteCurrent
|
$1.43M | USD | Point-in-time |
| Promissory Notes |
PromissoryNoteCurrent
|
$500.49K | USD | Point-in-time |
| September 2015 fixed rate convertible notes, net of discount of $0 and $1,237,500, respectively |
FixedConvertibleNotesPayableCurrent
|
$811.77K | USD | Point-in-time |
| September 2015 fixed rate convertible notes, net of discount of $0 and $1,237,500, respectively |
FixedConvertibleNotesPayableCurrent
|
- | USD | Point-in-time |
| Current portion of litigation settlement |
LitigationReserveCurrent
|
$339.48K | USD | Point-in-time |
| Current portion of litigation settlement |
LitigationReserveCurrent
|
$541.25K | USD | Point-in-time |
| Short term embedded derivative liabilities |
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityCurrent
|
$6.58M | USD | Point-in-time |
| Short term embedded derivative liabilities |
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityCurrent
|
$613.83K | USD | Point-in-time |
| Make-whole dividend liability |
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityCurrentDividendComponent
|
$500.18K | USD | Point-in-time |
| Make-whole dividend liability |
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiabilityCurrentDividendComponent
|
$849.56K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$18.10M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$10.13M | USD | Point-in-time |
| Accrued Litigation Settlement, net of current portion |
LitigationReserveNoncurrent
|
- | USD | Point-in-time |
| Accrued Litigation Settlement, net of current portion |
LitigationReserveNoncurrent
|
$339.50K | USD | Point-in-time |
| Long-Term Debt |
LongTermDebtNoncurrent
|
$5.28M | USD | Point-in-time |
| Long-Term Debt |
LongTermDebtNoncurrent
|
$5.44M | USD | Point-in-time |
| Accrued Warranty Liability |
StandardProductWarrantyAccrualNoncurrent
|
$176.46K | USD | Point-in-time |
| Accrued Warranty Liability |
StandardProductWarrantyAccrualNoncurrent
|
$264.00K | USD | Point-in-time |
| Commitments and Contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and Contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock, $0.0001 par value, 2,000,000,000 shares authorized; 554,223,320 and 7,759,844 shares issued and outstanding as of December 31, 2016 and December 31, 2015, respectively |
CommonStockValue
|
$15.52K | USD | Point-in-time |
| Common stock, $0.0001 par value, 2,000,000,000 shares authorized; 554,223,320 and 7,759,844 shares issued and outstanding as of December 31, 2016 and December 31, 2015, respectively |
CommonStockValue
|
$55.42K | USD | Point-in-time |
| Additional paid in capital |
AdditionalPaidInCapital
|
$369.89M | USD | Point-in-time |
| Additional paid in capital |
AdditionalPaidInCapital
|
$347.64M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-383.93M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-345.08M | USD | Point-in-time |
| Total stockholders equity (deficit) |
StockholdersEquity
|
$7.66M | USD | Point-in-time |
| Total stockholders equity (deficit) |
StockholdersEquity
|
$2.58M | USD | Point-in-time |
| Total stockholders equity (deficit) |
StockholdersEquity
|
$-13.99M | USD | Point-in-time |
| Total Liabilities and Stockholders Equity |
LiabilitiesAndStockholdersEquity
|
$18.75M | USD | Point-in-time |
| Total Liabilities and Stockholders Equity |
LiabilitiesAndStockholdersEquity
|
$11.61M | USD | Point-in-time |
Income Statement
32 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenues |
SalesRevenueNet
|
$6.54M | USD | Annual |
| Revenues |
SalesRevenueNet
|
$1.75M | USD | Annual |
| Cost of revenues (exclusive of depreciation shown below) |
CostOfSalesExcludingDepreciation
|
$9.56M | USD | Annual |
| Cost of revenues (exclusive of depreciation shown below) |
CostOfSalesExcludingDepreciation
|
$5.84M | USD | Annual |
| Research, development and manufacturing operations (exclusive of depreciation shown below) |
ResearchAndDevelopmentExpense
|
$6.71M | USD | Annual |
| Research, development and manufacturing operations (exclusive of depreciation shown below) |
ResearchAndDevelopmentExpense
|
$6.63M | USD | Annual |
| Selling, general and administrative (exclusive of depreciation shown below) |
SellingGeneralAndAdministrativeExpense
|
$12.36M | USD | Annual |
| Selling, general and administrative (exclusive of depreciation shown below) |
SellingGeneralAndAdministrativeExpense
|
$10.30M | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$3.60M | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$5.63M | USD | Annual |
| Impairment loss |
ImpairmentOfLongLivedAssetsHeldForUse
|
$12.57K | USD | Annual |
| Impairment loss |
ImpairmentOfLongLivedAssetsHeldForUse
|
- | USD | Annual |
| Total Costs and Expenses |
CostsAndExpenses
|
$26.38M | USD | Annual |
| Total Costs and Expenses |
CostsAndExpenses
|
$34.28M | USD | Annual |
| Loss from Operations |
OperatingIncomeLoss
|
$-27.75M | USD | Annual |
| Loss from Operations |
OperatingIncomeLoss
|
$-24.63M | USD | Annual |
| Other Income/(Expense), net |
OtherNonoperatingIncomeExpense
|
$82.77K | USD | Annual |
| Other Income/(Expense), net |
OtherNonoperatingIncomeExpense
|
$-60.29K | USD | Annual |
| Interest Expense |
InterestExpenseExcludingWarrantLiability
|
$26.55M | USD | Annual |
| Interest Expense |
InterestExpenseExcludingWarrantLiability
|
$7.90M | USD | Annual |
| Deemed interest expense on warrant liability |
InterestExpenseWarrantLiability
|
- | USD | Annual |
| Deemed interest expense on warrant liability |
InterestExpenseWarrantLiability
|
$909.09K | USD | Annual |
| Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net |
GainLossOnDerivativeAndExtinguishmentOfDebtNet
|
$9.47M | USD | Annual |
| Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net |
GainLossOnDerivativeAndExtinguishmentOfDebtNet
|
$-6.40M | USD | Annual |
| Total Other Income/(Expense) |
NonoperatingIncomeExpense
|
$-18.05M | USD | Annual |
| Total Other Income/(Expense) |
NonoperatingIncomeExpense
|
$-14.22M | USD | Annual |
| Net Loss |
NetIncomeLoss
|
$-45.80M | USD | Annual |
| Net Loss |
NetIncomeLoss
|
$-38.85M | USD | Annual |
| Net Loss Per Share (Basic and diluted) (in dollars per share) |
EarningsPerShareBasicAndDiluted
|
$-0.42 | USD | Annual |
| Net Loss Per Share (Basic and diluted) (in dollars per share) |
EarningsPerShareBasicAndDiluted
|
$-0.86 | USD | Annual |
| Weighted Average Common Shares Outstanding (Basic and diluted) (in shares) |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
53.48M | shares | Annual |
| Weighted Average Common Shares Outstanding (Basic and diluted) (in shares) |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
93.01M | shares | Annual |
Cash Flow Statement
87 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
NetIncomeLoss
|
$-45.80M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-38.85M | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$5.63M | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$3.60M | USD | Annual |
| Stock based compensation |
ShareBasedCompensation
|
$856.81K | USD | Annual |
| Stock based compensation |
ShareBasedCompensation
|
$888.35K | USD | Annual |
| Common stock issued for services |
IssuanceOfStockAndWarrantsForServicesOrClaims
|
- | USD | Annual |
| Common stock issued for services |
IssuanceOfStockAndWarrantsForServicesOrClaims
|
$90.00K | USD | Annual |
| Realized loss (gain) on sale of assets |
GainLossOnDispositionOfAssets1
|
$82.77K | USD | Annual |
| Realized loss (gain) on sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | Annual |
| Amortization of financing costs |
AmortizationOfFinancingCosts
|
$363.00K | USD | Annual |
| Amortization of financing costs |
AmortizationOfFinancingCosts
|
$137.11K | USD | Annual |
| Impairment loss |
ImpairmentOfLongLivedAssetsHeldForUse
|
$12.57K | USD | Annual |
| Impairment loss |
ImpairmentOfLongLivedAssetsHeldForUse
|
- | USD | Annual |
| Non-cash interest expense |
StockIssuedDuringPeriodValueIssuedForInterestExpenseExpensePortion
|
$948.90K | USD | Annual |
| Non-cash interest expense |
StockIssuedDuringPeriodValueIssuedForInterestExpenseExpensePortion
|
$1.44M | USD | Annual |
| Amortization of debt discount |
AmortizationOfDebtDiscountPremium
|
$6.21M | USD | Annual |
| Amortization of debt discount |
AmortizationOfDebtDiscountPremium
|
$23.97M | USD | Annual |
| Loss on Note Receivable |
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
- | USD | Annual |
| Loss on Note Receivable |
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
$99.00K | USD | Annual |
| Loss on Joint Venture |
EquityMethodInvestmentRealizedGainLossOnDisposal
|
$-128.71K | USD | Annual |
| Loss on Joint Venture |
EquityMethodInvestmentRealizedGainLossOnDisposal
|
- | USD | Annual |
| Bad debt expense |
ProvisionForDoubtfulAccounts
|
$77.52K | USD | Annual |
| Bad debt expense |
ProvisionForDoubtfulAccounts
|
$122.42K | USD | Annual |
| Accrued litigation settlement |
IncreaseDecreaseinAccruedLitigation
|
$-493.73K | USD | Annual |
| Accrued litigation settlement |
IncreaseDecreaseinAccruedLitigation
|
$-541.28K | USD | Annual |
| Deemed interest expense on warrant liability |
InterestExpenseWarrantLiability
|
- | USD | Annual |
| Deemed interest expense on warrant liability |
InterestExpenseWarrantLiability
|
$909.09K | USD | Annual |
| Change in fair value of derivatives and loss on extinguishment of liabilities, net |
GainLossOnDerivativeAndExtinguishmentOfDebtNet
|
$9.47M | USD | Annual |
| Change in fair value of derivatives and loss on extinguishment of liabilities, net |
GainLossOnDerivativeAndExtinguishmentOfDebtNet
|
$-6.40M | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-711.70K | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-1.32M | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$-1.70M | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$1.85M | USD | Annual |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidExpense
|
$-379.37K | USD | Annual |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidExpense
|
$-248.78K | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$1.49M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$2.06M | USD | Annual |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$-501.28K | USD | Annual |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$-1.22M | USD | Annual |
| Warranty reserve |
ProductWarrantyAccrualPeriodIncreaseDecrease
|
$-87.54K | USD | Annual |
| Warranty reserve |
ProductWarrantyAccrualPeriodIncreaseDecrease
|
$128.00K | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-16.86M | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-3.30M | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-22.10M | USD | Annual |
| Purchase of property, plant and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$29.19K | USD | Annual |
| Purchase of property, plant and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$51.72K | USD | Annual |
| Proceeds from sale of Assets |
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
$-82.77K | USD | Annual |
| Proceeds from sale of Assets |
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
- | USD | Annual |
| Investment in Joint Venture |
ProceedsFromDivestitureOfInterestInJointVenture
|
- | USD | Annual |
| Investment in Joint Venture |
ProceedsFromDivestitureOfInterestInJointVenture
|
$191.29K | USD | Annual |
| Interest income on restricted cash |
IncreaseDecreaseInRestrictedCashInterest
|
$49.45K | USD | Annual |
| Interest income on restricted cash |
IncreaseDecreaseInRestrictedCashInterest
|
- | USD | Annual |
| Patent activity costs |
PaymentsToAcquireIntangibleAssets
|
$189.46K | USD | Annual |
| Patent activity costs |
PaymentsToAcquireIntangibleAssets
|
$308.57K | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-158.41K | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-195.92K | USD | Annual |
| Payment of debt financing costs |
PaymentsOfFinancingCosts
|
$466.25K | USD | Annual |
| Payment of debt financing costs |
PaymentsOfFinancingCosts
|
$81.50K | USD | Annual |
| Proceeds from Promissory Note |
ProceedsFromNotesPayable
|
$500.00K | USD | Annual |
| Proceeds from Promissory Note |
ProceedsFromNotesPayable
|
$1.93M | USD | Annual |
| Repayment of debt |
RepaymentsOfBankDebt
|
$266.03K | USD | Annual |
| Repayment of debt |
RepaymentsOfBankDebt
|
$276.26K | USD | Annual |
| Repayment of convertible notes |
RepaymentsOfConvertibleDebt
|
$1.00M | USD | Annual |
| Repayment of convertible notes |
RepaymentsOfConvertibleDebt
|
- | USD | Annual |
| Proceeds from convertible notes |
ProceedsFromConvertibleDebt
|
- | USD | Annual |
| Proceeds from convertible notes |
ProceedsFromConvertibleDebt
|
$2.00M | USD | Annual |
| Restricted cash |
IncreaseDecreaseInRestrictedCash
|
$-9.25M | USD | Annual |
| Restricted cash |
IncreaseDecreaseInRestrictedCash
|
- | USD | Annual |
| Proceeds from Committed Equity Line |
ProceedsFromIssuanceOfPrivatePlacement
|
$1.06M | USD | Annual |
| Proceeds from Committed Equity Line |
ProceedsFromIssuanceOfPrivatePlacement
|
$2.00M | USD | Annual |
| Proceeds from issuance of stock and warrants |
ProceedsFromOtherEquity
|
$7.30M | USD | Annual |
| Proceeds from issuance of stock and warrants |
ProceedsFromOtherEquity
|
$14.18M | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$16.82M | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$19.31M | USD | Annual |
| Net change in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$-195.27K | USD | Annual |
| Net change in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$-2.99M | USD | Annual |
| Cash and cash equivalents at beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$130.95K | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$326.22K | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$3.32M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashAndCashEquivalentsAtCarryingValue
|
$130.95K | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashAndCashEquivalentsAtCarryingValue
|
$326.22K | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashAndCashEquivalentsAtCarryingValue
|
$3.32M | USD | Point-in-time |
| Cash paid for interest |
InterestPaid
|
$477.35K | USD | Annual |
| Cash paid for interest |
InterestPaid
|
$417.88K | USD | Annual |
| Non-cash conversions of preferred stock and convertible notes to equity |
Noncashconversions
|
$10.62M | USD | Annual |
| Non-cash conversions of preferred stock and convertible notes to equity |
Noncashconversions
|
$19.99M | USD | Annual |
Stockholders Equity
22 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Beginning balance |
StockholdersEquity
|
$7.66M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$2.58M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$-13.99M | USD | Point-in-time |
| Conversion of shares |
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
$25.56M | USD | Annual |
| Conversion of shares |
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
$58.82K | USD | Annual |
| Interest and Dividend Expense paid with Common Stock |
StockIssuedDuringPeriodValueIssuedForInterestExpenseEquity
|
$256.78K | USD | Annual |
| Interest and Dividend Expense paid with Common Stock |
StockIssuedDuringPeriodValueIssuedForInterestExpenseEquity
|
$1.03M | USD | Annual |
| Issuance of Restricted Stock |
StockIssuedDuringPeriodValueShareBasedCompensation
|
- | USD | Annual |
| Issuance of Restricted Stock |
StockIssuedDuringPeriodValueShareBasedCompensation
|
- | USD | Annual |
| Common Stock Issued to Placement Agent |
StockIssuedDuringPeriodValueIssuedToPlacementAgent
|
$108.98K | USD | Annual |
| Commitment Shares |
StockIssuedDuringPeriodValueCommitmentFee
|
$54.00K | USD | Annual |
| Commitment Shares |
StockIssuedDuringPeriodValueCommitmentFee
|
- | USD | Annual |
| Common shares issued in payment of consulting expenses |
StockIssuedDuringPeriodValueIssuedForServices
|
$90.00K | USD | Annual |
| Stock based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$888.35K | USD | Annual |
| Stock based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$856.81K | USD | Annual |
| Conversion of October 2016 Convertible Notes into Common Shares, plus make-whole |
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
$1.38M | USD | Annual |
| Conversion of October 2016 Convertible Notes into Common Shares, plus make-whole |
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
$481.56K | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-45.80M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-38.85M | USD | Annual |
| Ending balance |
StockholdersEquity
|
$7.66M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$2.58M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$-13.99M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.